Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.
News: Breast Cancer
Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.
Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization.
Amanda Mathis went from being a patient at Vanderbilt-Ingram Cancer Center to becoming a member of the cancer center’s Board of Overseers.
Tuya Pal, M.D., associate professor of medicine and Ingram Associate Professor of Cancer Research., specializes in cancer genetics and health disparities among diverse populations.
Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.
Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.
Health & Wellness would like to celebrate you and support breast cancer awareness by creating an “Awareness Saves Lives” faculty and staff survivor banner. The banner will be displayed as part of the 2017 Breast Cancer Awareness Expo scheduled for Oct. 4 from 11 a.m. to 1 p.m. in the Light Hall North Lobby.
Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers. Carlos L. Arteaga, M.D. More than 40,000 American women will die from breast […]
Stress stimulates the formation of blood vessels in bone and may help breast cancer cells to invade this organ. In the July issue of the Journal of Bone and Mineral Research, Florent Elefteriou, Ph.D., Julie A. Sterling, Ph.D., and colleagues describe a mechanism for skeletal colonization by breast cancer cells that could lead to new ways to […]